[SRNE] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
25-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- -49.72%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Annual Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 4,590 3,825 460 584 529 683 5 211.58%
PBT -13,760 -36,359 -21,911 -4,845 -3,236 -1,808 -942 56.31%
Tax 36,314 -1,702 10 15 12 8 24 238.63%
NP -45,811 -34,657 -21,911 -4,845 -3,236 -1,808 -942 90.99%
Tax Rate - - - - - - - -
Total Cost 50,401 38,482 22,371 5,429 3,766 2,491 948 93.85%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -998.06 -906.07 -4,761.79 -830.00 -611.60 -264.94 -17,407.46 -37.88%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -1.24 -1.30 -1.46 -0.42 -0.33 -0.20 -0.15 42.17%
EPS Diluted -1.24 -1.30 -1.46 -0.42 -0.33 -0.20 -0.15 42.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.